Journal of Hepatology

Instructions for Authors
pp. II-V(4)

Editorial Board
pp. v-v(1)

The fourth year in Barcelona
pp. 1-1(1)
Authors: Gines P.; Rodes J.

The Bridge-January 2004
pp. 2-2(1)

De novo autoimmune hepatitis after liver transplantation
pp. 3-7(5)
Authors: Mieli-Vergani G.; Vergani D.

Studies on the mechanism of accumulation of cholesterol in the gallbladder mucosa. Evidence that sterol 27-hydroxylase is not a pathogenetic factor
pp. 8-13(6)
Authors: Stromsten A.; von Bahr S.; Bringman S.; Saeki M.; Sahlin S.; Bjorkhem I.; Einarsson C.

Transcriptional reprogramming in murine liver defines the physiologic consequences of biliary obstruction
pp. 14-23(10)
Authors: Campbell K.M.; Sabla G.E.; Bezerra J.A.

A progressive familial intrahepatic cholestasis type 2 mutation causes an unstable, temperature-sensitive bile salt export pump
pp. 24-30(7)
Authors: Plass J.R.M.; Mol O.; Heegsma J.; Geuken M.; de Bruin J.; Elling G.; Muller M.; Faber K.N.; Jansen P.L.M.

Microbial mimics are major targets of crossreactivity with human pyruvate dehydrogenase in primary biliary cirrhosis
pp. 31-39(9)
Authors: Bogdanos D.-P.; Baum H.; Grasso A.; Okamoto M.; Butler P.; Ma Y.; Rigopoulou E.; Montalto P.; Davies E.T.; Burroughs A.K.; Vergani D.

A randomized placebo controlled trial of vitamin E for alcoholic hepatitis
pp. 40-46(7)
Authors: Mezey E.; Potter J.J.; Rennie-Tankersley L.; Caballeria J.; Pares A.

The methionine-choline deficient dietary model of steatohepatitis does not exhibit insulin resistance
pp. 47-51(5)
Authors: Rinella M.E.; Green R.M.

Green tea polyphenol epigallocatechin-3-gallate inhibits platelet-derived growth factor-induced proliferation of human hepatic stellate cell line LI90
pp. 52-59(8)
Authors: Sakata R.; Ueno T.; Nakamura T.; Sakamoto M.; Torimura T.; Sata M.

4-Hydroxynonenal as a selective pro-fibrogenic stimulus for activated human hepatic stellate cells
pp. 60-68(9)
Authors: Zamara E.; Novo E.; Marra F.; Gentilini A.; Romanelli R.G.; Caligiuri A.; Robino G.; Tamagno E.; Aragno M.; Danni O.; Autelli R.; Colombatto S.; Dianzani M.U.; Pinzani M.; Parola M.

Corticosteroids stimulate selectively transforming growth factor (TGF)- receptor type III expression in transdifferentiating hepatic stellate cells
pp. 69-76(8)
Authors: Wickert L.; Abiaka M.; Bolkenius U.; Gressner A.M.

Proapoptotic effect of hepatitis C virus CORE protein in transiently transfected cells is enhanced by nuclear localization and is dependent on PKR activation
pp. 77-85(9)
Authors: Realdon S.; Gerotto M.; Dal Pero F.; Marin O.; Granato A.; Basso G.; Muraca M.; Alberti A.

Melatonin inhibits nuclear factor kappa B activation and oxidative stress and protects against thioacetamide induced liver damage in rats
pp. 86-93(8)
Authors: Bruck R.; Aeed H.; Avni Y.; Shirin H.; Matas Z.; Shahmurov M.; Avinoach I.; Zozulya G.; Weizman N.; Hochman A.

Pirfenidone prevents endotoxin-induced liver injury after partial hepatectomy in rats
pp. 94-101(8)
Authors: Tsuchiya H.; Kaibori M.; Yanagida H.; Yokoigawa N.; Kwon A.-H.; Okumura T.; Kamiyama Y.

Ex vivo characterization of tumor-derived melanoma antigen encoding gene-specific CD8+cells in patients with hepatocellular carcinoma
pp. 102-109(8)
Authors: Zerbini A.; Pilli M.; Soliani P.; Ziegler S.; Pelosi G.; Orlandini A.; Cavallo C.; Uggeri J.; Scandroglio R.; Crafa P.; Spagnoli G.C.; Ferrari C.; Missale G.

The regulation of liver regeneration by the plasmin/₂-antiplasmin system
pp. 110-116(7)
Authors: Okada K.; Ueshima S.; Imano M.; Kataoka K.; Matsuo O.

Hexokinase II and VEGF expression in liver tumors: correlation with hypoxia-inducible factor-1 and its significance
pp. 117-123(7)
Authors: Yasuda S.; Arii S.; Mori A.; Isobe N.; Yang W.; Oe H.; Fujimoto A.; Yonenaga Y.; Sakashita H.; Imamura M.

The critical issue of hepatocellular carcinoma prognostic classification: which is the best tool available?
pp. 124-131(8)
Authors: Cillo U.; Bassanello M.; Vitale A.; Grigoletto F.A.; Burra P.; Fagiuoli S.; D'Amico F.; Ciarleglio F.A.; Boccagni P.; Brolese A.; Zanus G.; D'Amico D.F.

Intracellular trafficking during liver regeneration - Alterations in late endocytic and transcytotic pathways
pp. 132-139(8)
Authors: Fernandez M.A.; Turro S.; Ingelmo-Torres M.; Enrich C.; Pol A.

Effects of treatment of hepatorenal syndrome before transplantation on posttransplantation outcome. A case-control study
pp. 140-146(7)
Authors: Restuccia T.; Ortega R.; Guevara M.; Gines P.; Alessandria C.; Ozdogan O.; Navasa M.; Rimola A.; Garcia-Valdecasas J.C.; Arroyo V.; Rodes J.

Overweight and obesity, hepatic steatosis, and progression of chronic hepatitis C: a retrospective study on a large cohort of patients in the United States
pp. 147-154(8)
Authors: Hu K.-Q.; Kyulo N.L.; Esrailian E.; Thompson K.; Chase R.; Hillebrand D.J.; Runyon B.A.

MAGE antigens: therapeutic targets in hepatocellular carcinoma?
pp. 155-158(4)
Authors: Sarobe P.; Feijoo E.; Alfaro C.; Mazzolini G.; Melero I.

The growing evidence that renal function should be improved in patients with cirrhosis and hepatorenal syndrome before liver transplantation
pp. 159-161(3)
Author: Moreau R.

Magnetic resonance imaging of liver tumors
pp. 162-171(10)
Authors: Lencioni R.; Cioni D.; Crocetti L.; Pina C.D.; Bartolozzi C.

Pharmacological thrombolysis in Budd Chiari syndrome: a single centre experience and review of the literature
pp. 172-180(9)
Authors: Sharma S.; Texeira A.; Texeira P.; Elias E.; Wilde J.; Olliff S.P.

Hepatic arterial buffer response: visualization by multiphasic high-resolution 3D magnetic resonance angiography
pp. 181-181(1)
Authors: Gulberg V.; Schoenberg S.O.

Lack of detection of novel nonsense mutations on exon 3 of hemochromatosis gene in patients with hepatic iron overload
pp. 182-183(2)
Authors: Rosa I.; De Roux N.; Pelletier G.; Lazure T.; Chousterman M.; Buffet C.

Protease inhibitors for treatment of chronic hepatitis C-a new target for the magic bullet identified
pp. 184-186(3)
Author: Ferenci P.

Prevention of HBV reactivation from anti-HBc-positive liver grafts: searching for the consensus
pp. 186-188(3)
Author: Roque Afonso A.M.